PTI-428 Uses, Dosage, Side Effects and more

PTI-428 is under investigation in clinical trial NCT03258424 (Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy).

Attribute	Details
Trade Name	PTI-428
Generic	PTI-428
Type
Formula	C18H18N4O4
Weight	Average: 354.366 Monoisotopic: 354.132805076
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph